Cardiac Flashcards
Aetiology of HTN
95% essential Renal artery stenosis Hyperthyroidism PCKD Chronic pyelonephritis Diabetic nephropathy RCC Cushing's Phaeochromocytoma Hyperaldosteronism
Symptoms
Asymptomatic
May get headaches
Stages of HTN
Stage 1 > 140/90 ABPM >135/85
Stage 2 > 160/100 ABPM > 150/95
Stage 4 >180/120
Signs
Retinal haemorrhage Papilloedema
Risk factors
Age 65 yo - men 65 - 74 - female Black African and Asian FHx Social deprivation Lifestyle - smoking and alcohol Anxiety and emotional stress
Complications
Increased risk of: Heart failure. Coronary artery disease Stroke Chronic kidney disease Peripheral arterial disease Vascular dementia
Diagnosis
If blood pressure measured in the clinic is 140/90 - 180/120mmHg: ambulatory blood pressure monitoring (ABPM) to confirm the diagnosis of hypertension
Person’s blood pressure is 180/120 mmHg or higher
Refer for same-day specialist assessment if there are:
- Signs of retinal haemorrhage and/or papilloedema
- new onset confusion, chest pain, signs of HF or AKI
if not:
- Ix for organ damage e.g. eGFR for kidney damage
- tarting antihypertensive drug treatment immediately if organ damage
If no target organ damage is identified:
- repeat blood pressure measurement within 7 days
Assess for target organ damage
Urine dipstick:
- haematuria
- alb: Cr ratio
HbA1C
ECG
Serum LDL - QRISK
Mx
Lifestyle advice
- diet and exercise
- reduce caffeine
- reduce salt
- smoking and alcohol cessation
Antihypertensives
Antihypertensive procedure
Stage 1 - ACEi/ARB
- if have T2DM
- less than 55 yo
Stage 1 - CCB
- over 55 yo
- Afro-carribean
Stage 2 - ACEi/ARB +CCB
Stage 3 - ACEi/ARB +CCB + thiazide like diuretic
Stage 4 ACEi/ARB +CCB + thiazide like diuretic + beta blocker or alpha/beta blocker if K+ >4.5 mmol/l
Target BP for 80 years and over
< 150/90 mmHg.
Annual review
Adherence
BP
eGFR
QRISK
Pre - eclampsia
BP > 140/90 after 20 wks gestation
- Proteinuria
- Severe headache
- Visual disturbances
Complications:
- Renal insufficiency
- Liver issue - ALT/AST
- eclampsia
Risk factors for pre - eclampsia
PMHx of pre - eclampsia CKD T1/T2DM HTN SLE 40+ Obese FHx
Mx of pre-eclampsia
Aspirin 75 - 150mg prescribed form 12 wks - if high risk
Labetalol
Urine dipstick
- proteinuria 30mg
- haematuria
When to suspect familial hypercholesterolaemia
Total cholesterol conc > 7.5 mmol/L
Personal or FHx of premature CHD < 60yo
Signs of hypercholesterolaemia
Xanthelasma
Corneal arcus
Tendon xanthoma
Secondary hyperlipidaemia
Caused by: T2DM Obesity Nephrotic syndrome Alcoholism Cushing's syndrome Hypothyroidism
Drugs:
Corticosteroids
Thiazide diuretic
Cardiovascular risk reduction
Primary reduction:
QRISK > 10%
Atorvastatin 20mg
Secondary reducation:
Atorvastatin 80mg
Contraindicated - ezetimibe 10mg
Follow up bloods 3 months and 12 months after starting statin
Familial hypercholesterolaemia diagnosis
Adults: LDL cholesterol 13+ mmol/L.
Child: LDL cholesterol 11+ mmol/L
Use the Simon Broome criteria or the Dutch Lipid Clinic Network
Dutch Lipid Clinic Network
Definite’ FH > 8
‘Probable’ FH 6–8
‘Possible’ FH 3–5
‘Unlikely’ FH < 3
When is Qrisk not needed
TIDM and 40+
Has had diabetes for 10+ years
Has established nephropathy
Has other CVD risk factors
Causes of angina
Insufficient blood supply to the myocardium:
- Previous MI
- Atherosclerosis - coronary artery disease
Risk factors for angina
Male Age FHx Ethnicity - Black and asian Increased QRISK Smoking High cholesterol and lipids HTN, DM, CKD
Symptoms of angina
Stable: Pain when exerting, relieved at rest
Relieved by GTN spray
Unstable angina: Pain at rest too
Atypical symptoms:
- GI discomfort
- Dyspnoea
- Nausea
Angina impact on life
Reduced exercise tolerance
If severe, may not be able to leave home
Investigations for angina
Bloods
- FBC
- Trop I
- CRP
- Lipids
- HbA1c
ECG
QRISK
Advice for angina
If experiencing chest pain:
- rest and stop what you are doing
- GTN spray
- Second dose after 5 mins
- If pain not relieved within 15 mins call 999
- avoid cold, emotional stress and large meals
- If occurs when driving, stop driving and recommence once pain has subsided
Conservative mx of angina
Smoking cessation
Exercise
Reduce alcohol intake
Healthier diet - less salt and cholesterol
Angina mx
GTN spray
Beta blocker or CCB
Secondary prevention of CVD
- aspirin 75mg
- ACEi - if DM
- Statin - atorvastatin 20mg
Angina follow up
4 week follow up - check response to treatment
Review every 6 months to 1 year
Unstable angina Ix and mx
History
Cardiovascular examination
ECG
Bloods - trop I, HbA1c, lipids
GRACE score
Mx:
- Referral
GRACE score
Predict 6-month mortality and risk of cardiovascular events.
ACS
Acute coronary syndrome:
- STEMI
- NSTEMI
- Unstable angina
Causes
Coronary vascular disease
Risk factors
Previous MI Male Age Ethnicity - black or asian HTN, DM, CKD High cholesterol or lipids High QRISK FHx
Symptoms of MI
Central dull crushing chest pain Gradual onset Radiates to arm, jaw and neck Sweating N+V
Signs of MI
Bloods
- increased troponin I
- not increased with unstable angina
ECG:
STEMI - ST elevation
NSTEMI - ST depression
Unstable angina - ST depression
Previous MI
- LBBB
- Pathological Q wave
ACS impact on lifestyle
Reduced exercise tolerance
HF - breathlessness and oedema
Increased risk of second MI
Ix for ACS
Bloods:
- FBC
- Lipids
- U+Es
- LFTs
- BM
- TSH
- Trop I
ECG
Mx of ACS
Immediate referral
- STEMI - PCI
Conservative mx
Weight loss Reduced salt and cholesterol intake Smoking cessation Reduce alcohol consumption Increase exercise
Medication for ACS
STEMI/NSTEMI: Acute - morphine, oxygen, nitrates, aspirin Tripe therapy - warfarin, DOAC, aspirin Beta blocker/ CCB ACEi Statin - atorvastatin 80mg
Unstable angina:
- Acute - morphine
- GTN spray
- Aspiring 300mg
Atrial fibrillation
Supraventricular tachyarrhythmia resulting from irregular, disorganized electrical activity and ineffective contraction of the atria
Types of AF
Paroxysmal AF — episodes lasting longer than 30 seconds but less than 7 days.
- Self terminating
Persistent AF — episodes lasting longer than 7 days
- or less than seven days but requiring pharmacological or electrical cardioversion
Permanent AF — AF that fails to terminate using cardioversion, AF that is terminated but relapses within 24 hours, or longstanding AF (usually longer than 1 year)
Causes of AF
Congestive heart failure
Rheumatic valvular disease
Atrial or ventricular dilation or hypertrophy
Pre-excitation syndromes (such as Wolff–Parkinson–White syndrome)
Sick sinus syndrome
Congenital heart disease
Inflammatory or infiltrative disease (such as pericarditis, amyloidosis, or myocarditis).
Risk factors for AF
Excessive caffeine intake Alcohol abuse Obesity Smoking Medication - thyroxine or bronchodilators
Complications of AF
Stroke and thromboembolism
Heart failure
Diagnosis AF
Clinical history
Cardiovascular examination
- pulse irregularly irregular
ECG
Presentation of AF
Breathlessness. Palpitations. Chest discomfort. Syncope or dizziness. Reduced exercise tolerance
Mx of AF
Onset within 48 hours and haemodynamically - urgently admit for electric cardioversion
Onset within 48 hours and stable - urgently admit for cardioversion (may be drug)
If symptomatic - urgent referral
CHADVASC - 2+ - anticoag
HAS-BLED - risk of major bleed
Medication
Rate control:
- beta blocker or CCB
- digoxin - non‑paroxysmal atrial fibrillation who are sedentary
Rhythm control:
- Flecainide
- Amiodarone
Anticoagulants:
- apixaban, dabigatran or rivaroxaban `
AF follow up
Within 1 week of starting rate-control treatment
Review the person at least annually once symptoms are controlled
Heart failure
Ability of the heart to maintain the circulation of blood is impaired as a result of a structural or functional impairment of ventricular filling or ejection
New York Heart Association (NYHA)
Class I — no limitation of physical activity.
Class II — slight limitation of physical activity. Comfortable at rest but ordinary physical activity results in undue breathlessness, fatigue, or palpitations.
Class III — marked limitation of physical activity. Comfortable at rest but less than ordinary physical activity results in undue breathlessness, fatigue, or palpitations.
Class IV — unable to carry out any physical activity without discomfort. Symptoms at rest can be present.
Causes of HF
IHD - most Coronary artery disease HTN Pregnancy. Infiltrative - sarcoidosis, amyloidosis, haemochromatosis Aortic stenosis Pericarditis AF Nephrotic syndrome
Risk factors
Alcohol
Cocaine
Obesity
Smoking
Presentation of HF
Breathlessness on exertion Orthopnoea Paroxysmal nocturnal dyspnoea Fluid retention Fatigue, decreased exercise tolerance Light headedness or history of syncope
Signs of HF
Tachycardia Laterally displaced apex beat Hypertension Raised jugular venous pressure Enlarged liver Basal crepitations Oedema
Diagnosis
History Cardiac examination Bloods - BNP - HbA1C ECG Urine dipstick QRISK
Mx of heart failure with reduced ejection fraction
Furosemide
ACEi + Beta blocker
Statin - QRISK
Supervised exercise-based group rehabilitation programme
Mx of heart failure with preserved ejection fraction
Furosemide
Statin
Supervised exercise-based group rehabilitation programme
Consider if an antiplatelet drug is indicated
End-stage heart failure mx
At high risk of dying within the next 6–12 months
- Set realistic goals of care with the person and their family/carers.
- MDT
- Review medication
- Advance care plan
HF follow up
Frequency of follow up individualized to the severity and stability of symptoms, treatment, and comorbidities
Person’s clinical condition or drugs have changed - 2 weeks
Stable - at least every 6 months